Simulations Plus Inc
NASDAQ:SLP
Intrinsic Value
Simulations Plus, Inc. provides modeling and simulation software and consulting services supporting drug discovery, development research and regulatory submissions. [ Read More ]
The intrinsic value of one SLP stock under the Base Case scenario is 16.08 USD. Compared to the current market price of 45.25 USD, Simulations Plus Inc is Overvalued by 64%.
Valuation Backtest
Simulations Plus Inc
Run backtest to discover the historical profit from buying and selling SLP stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Simulations Plus Inc
Current Assets | 128m |
Cash & Short-Term Investments | 108.5m |
Receivables | 15.7m |
Other Current Assets | 3.7m |
Non-Current Assets | 66m |
Long-Term Investments | 9m |
PP&E | 1.9m |
Intangibles | 52.2m |
Other Non-Current Assets | 2.8m |
Current Liabilities | 14.5m |
Accounts Payable | 360k |
Accrued Liabilities | 6.6m |
Other Current Liabilities | 7.6m |
Non-Current Liabilities | 2.4m |
Other Non-Current Liabilities | 2.4m |
Earnings Waterfall
Simulations Plus Inc
Revenue
|
64.7m
USD
|
Cost of Revenue
|
-16.1m
USD
|
Gross Profit
|
48.6m
USD
|
Operating Expenses
|
-39.4m
USD
|
Operating Income
|
9.2m
USD
|
Other Expenses
|
1.3m
USD
|
Net Income
|
10.5m
USD
|
Free Cash Flow Analysis
Simulations Plus Inc
What is Free Cash Flow?
SLP Profitability Score
Profitability Due Diligence
Simulations Plus Inc's profitability score is 61/100. The higher the profitability score, the more profitable the company is.
Score
Simulations Plus Inc's profitability score is 61/100. The higher the profitability score, the more profitable the company is.
SLP Solvency Score
Solvency Due Diligence
Simulations Plus Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.
Score
Simulations Plus Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
SLP Price Targets Summary
Simulations Plus Inc
According to Wall Street analysts, the average 1-year price target for SLP is 54.74 USD with a low forecast of 51.51 USD and a high forecast of 57.75 USD.
Ownership
SLP Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Shareholder Return
SLP Price
Simulations Plus Inc
Average Annual Return | 33.51% |
Standard Deviation of Annual Returns | 91.27% |
Max Drawdown | -62% |
Market Capitalization | 904.3m USD |
Shares Outstanding | 20 279 000 |
Percentage of Shares Shorted | 10.78% |
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Simulations Plus, Inc. provides modeling and simulation software and consulting services supporting drug discovery, development research and regulatory submissions. The company is headquartered in Lancaster, California and currently employs 135 full-time employees. The company provides prediction of properties of molecules utilizing artificial-intelligence- and machine-learning-based technology. The company also provides consulting services ranging from early drug discovery through preclinical and clinical trial development to regulatory submissions in support of product approval. The company offers 11 software products for pharmaceutical research and development, which includes GastroPlus, DDDPlus, MembranePlus, DILIsym, NAFLDsym, ADMET Predictor, MedChem Designer, MedChem Studio, PKPlus, KIWI and Monolix Suite of products through Lixoft. Its software and consulting services are provided to pharmaceutical, biotechnology, agrochemical, cosmetics, and food industry companies and to academic and regulatory agencies worldwide for use in the conduct of industry-based research. Cognigen Corporation, DILIsym Services, Inc. and Lixoft are its subsidiaries.
Contact
IPO
Employees
Officers
The intrinsic value of one SLP stock under the Base Case scenario is 16.08 USD.
Compared to the current market price of 45.25 USD, Simulations Plus Inc is Overvalued by 64%.